Moore Brian J, White Susan, Washington Raynard, Coenen Natalia, Elixhauser Anne
*IBM Watson Health, Ann Arbor, MI †The Ohio State University, Columbus, OH ‡Department of Public Health, PA §IBM Watson Health, Santa Barbara, CA ∥Agency for Healthcare Research and Quality, Center for Quality Improvement and Patient Safety, Rockville, MD.
Med Care. 2017 Jul;55(7):698-705. doi: 10.1097/MLR.0000000000000735.
We extend the literature on comorbidity measurement by developing 2 indices, based on the Elixhauser Comorbidity measures, designed to predict 2 frequently reported health outcomes: in-hospital mortality and 30-day readmission in administrative data. The Elixhauser measures are commonly used in research as an adjustment factor to control for severity of illness.
We used a large analysis file built from all-payer hospital administrative data in the Healthcare Cost and Utilization Project State Inpatient Databases from 18 states in 2011 and 2012.
The final models were derived with bootstrapped replications of backward stepwise logistic regressions on each outcome. Odds ratios and index weights were generated for each Elixhauser comorbidity to create a single index score per record for mortality and readmissions. Model validation was conducted with c-statistics.
Our index scores performed as well as using all 29 Elixhauser comorbidity variables separately. The c-statistic for our index scores without inclusion of other covariates was 0.777 (95% confidence interval, 0.776-0.778) for the mortality index and 0.634 (95% confidence interval, 0.633-0.634) for the readmissions index. The indices were stable across multiple subsamples defined by demographic characteristics or clinical condition. The addition of other commonly used covariates (age, sex, expected payer) improved discrimination modestly.
These indices are effective methods to incorporate the influence of comorbid conditions in models designed to assess the risk of in-hospital mortality and readmission using administrative data with limited clinical information, especially when small samples sizes are an issue.
我们在埃利克斯豪泽共病测量方法的基础上开发了两个指数,以扩展共病测量方面的文献,这两个指数旨在预测行政数据中两个经常报告的健康结局:住院死亡率和30天再入院率。埃利克斯豪泽测量方法在研究中通常用作控制疾病严重程度的调整因素。
我们使用了一个大型分析文件,该文件由2011年和2012年来自18个州的医疗保健成本和利用项目州住院数据库中的所有支付方医院行政数据构建而成。
最终模型是通过对每个结局进行反向逐步逻辑回归的自抽样复制得出的。为每个埃利克斯豪泽共病生成比值比和指数权重,以便为每条记录创建一个用于死亡率和再入院率的单一指数得分。使用c统计量进行模型验证。
我们的指数得分与分别使用所有29个埃利克斯豪泽共病变量的效果相同。我们的指数得分在不纳入其他协变量的情况下,死亡率指数的c统计量为0.777(95%置信区间为0.776 - 0.778),再入院率指数的c统计量为0.634(95%置信区间为0.633 - 0.634)。这些指数在由人口统计学特征或临床状况定义的多个子样本中是稳定的。添加其他常用协变量(年龄、性别、预期支付方)可适度提高区分度。
这些指数是有效的方法,可将共病状况的影响纳入旨在使用临床信息有限的行政数据评估住院死亡率和再入院风险的模型中,尤其是在样本量较小的情况下。